Genmab has entered into a binding agreement to acquire Merus, with both companies’ boards unanimously approving the transaction, which is expected to close in...
Naveris, Inc., a leader in molecular diagnostics for viral cancers, announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic.
The...
